Antiviral therapy can reverse the development of immune senescence in elderly mice with latent cytomegalovirus infection
about
Acyclovir Therapy Reduces the CD4+ T Cell Response against the Immunodominant pp65 Protein from Cytomegalovirus in Immune Competent IndividualsAging and HIV/AIDS: pathogenetic role of therapeutic side effectsCytomegalovirus Reinfections Stimulate CD8 T-Memory InflationThe Avalanche is Coming … And Just Now It's Starting to Snow.Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease.Impact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy.The two faces of heterologous immunity: protection or immunopathology.Expansions of Cytotoxic CD4+CD28- T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are Triggered by CMV Infection.An attenuated temperature-sensitive strain of cytomegalovirus (tsm5) establishes immunity without development of CD8(+) T cell memory inflation.Immune Protection against Virus Challenge in Aging Mice Is Not Affected by Latent Herpesviral Infections.Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors.Cytomegalovirus infection and progressive differentiation of effector-memory T cellsThe impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancerCD28 pro-atherogenic CD4 T-cells explain the link between CMV infection and an increased risk of cardiovascular deathHuman Cytomegalovirus Latency: Targeting Differences in the Latently Infected Cell with a View to Clearing Latent Infection
P2860
Q28546851-BE0AC8BF-D068-4730-9F4C-FCCE6977B2D0Q34089694-3A0951A4-82CE-44FA-A576-A0E0DE04BB66Q36199934-60EEB85C-B8D5-40A9-9ACE-1AA5C4F492B6Q36952148-77DF7C4A-69F9-4FCD-BD05-874009CCD17BQ37037056-2A6DAF58-8A90-4160-AE79-8207BE9F5CCBQ37077610-CAE890BF-6A35-46AC-8299-8EF6B0C97B92Q37581439-5995512B-C620-4108-865D-4CC66F74C5E4Q37675607-B0D3A165-3E73-4137-8C51-1C673BB5BD41Q39384845-F2577145-3D64-4310-9AAB-F7753CA97648Q41015937-AD28EDF7-ADA8-427B-89D8-8B5E050C6935Q42275032-24777A99-96BE-4F61-898F-4DA572669FA3Q57821275-3296EDEA-9FCF-4DC6-8833-50A664A916E0Q58484770-9C0E46C3-17A9-44F3-8CA6-FED565F313BBQ58796708-39B6B797-D31A-4705-99CD-8D19F3801CFAQ59072631-6C5E44FF-FB05-421D-9BBA-BB01D32EFDC6
P2860
Antiviral therapy can reverse the development of immune senescence in elderly mice with latent cytomegalovirus infection
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Antiviral therapy can reverse ...... tent cytomegalovirus infection
@ast
Antiviral therapy can reverse ...... tent cytomegalovirus infection
@en
type
label
Antiviral therapy can reverse ...... tent cytomegalovirus infection
@ast
Antiviral therapy can reverse ...... tent cytomegalovirus infection
@en
prefLabel
Antiviral therapy can reverse ...... tent cytomegalovirus infection
@ast
Antiviral therapy can reverse ...... tent cytomegalovirus infection
@en
P2093
P2860
P356
P1433
P1476
Antiviral therapy can reverse ...... tent cytomegalovirus infection
@en
P2093
Annette Pachnio
Clive Sweet
Mark Beswick
Paul A Moss
Sarah N Lauder
P2860
P304
P356
10.1128/JVI.02427-12
P407
P577
2012-10-31T00:00:00Z